Continuing Access to In-Home IVIG Act
Official title: To amend the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to extend the Medicare Patient IVIG Access Demonstration Project.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Continuing Access to In-Home IVIG Act
This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 7839: Continuing Access to In-Home IVIG Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-7839/
"H.R. 7839: Continuing Access to In-Home IVIG Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-7839/.
H.R. 7839, 116th Cong. (2026), https://openamerica.io/bill/116-HR-7839/.
[H.R. 7839: Continuing Access to In-Home IVIG Act](https://openamerica.io/bill/116-HR-7839/)